General Hospital Psychiatry
Volume 25, Issue 2 , Pages 140-142 , March 2003

Levodopa improved rapid eye movement sleep behavior disorder with diffuse Lewy body disease

  • Ken Yamauchi, MD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Minako Takehisa, MD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Mami Tsuno, MD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Yasuhiro Kaneda, MD, PhD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Takahide Taniguchi, MD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Hiromi Ohno, MD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Hiroyoshi Sei, MD, PhD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Yusuke Morita, MD, PhD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan
    • ,
  • Teturo Ohmori, MD, PhD

      Affiliations

    • University of Tokushima School of Medicine, Tokushima, Japan

References 

  1. Schenck CH, Bundlie SR, Ettinger MG, et al.  Chronic behavioral disorders of human REM sleep (a new category of parasomnia). Sleep. 1986;9:293–308
  2. Ringman JM, Simmons JH. Treatment of REM sleep behavior disorder with donepezil (a report of three cases). Neurology. 2000;55:870–871
  3. Bamford CR. Carbamazepine in REM sleep behavior disorder. Sleep. 1993;16:33–34
  4. Albin RL, Koeppe RA, Chervin RD, et al.  Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55:1410–1412
  5. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord. 1996;11:214–216
  6. Hoehn MM, Yahr MD. Parkinsonism (onset, progression and mortality). Neurology. 1967;17:427–442
  7. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state:” (a practical method for grading the cognitive state of patients for the clinician). J Psychiatr Res. 1975;12:189–198
  8. McKeith IG, Galasko D, Kosaka K, et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) (report of the consortium on DLB international workshop). Neurology. 1996;47:1113–1124
  9. Diagnostic Classification Steering Committee, Thorpy MJ, chairman. REM sleep behavior disorder. In: International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990: 177–180
  10. Trampus M, Ferri N, Adami M, Ongini E. The dopamine D1 receptor agonists, A68930 and SKF 38393, induced arousal and suppress REM sleep in the rat. Eur J Pharmacol. 1993;235:83–87
  11. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M. Differental effects of dopamine D1 and D2 receptor antagonist antipsychotics on the sleep pattern in the rat. J Pharmacol Exp Ther. 1993;266:726–731
  12. Askenasy JJ, Yahr MD. Reversal of sleep disturbance in Parkinson’s disease by antiparkinsonian therapy (a preliminary study). Neurology. 1985;35:527–532

PII: S0163-8343(03)00003-3

doi: 10.1016/S0163-8343(03)00003-3

General Hospital Psychiatry
Volume 25, Issue 2 , Pages 140-142 , March 2003

Article Tools

* Image Usage & Resolution